GSA Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,717
| Closed | -$236K | – | 1637 |
|
|
2024
Q4 | $236K | Buy |
+1,717
| New | +$236K | 0.02% | 1334 |
|
|
2024
Q2 | – | Sell |
-6,564
| Closed | -$992K | – | 1613 |
|
|
2024
Q1 | $992K | Buy |
+6,564
| New | +$992K | 0.08% | 443 |
|
|
2022
Q1 | – | Sell |
-8,175
| Closed | -$1.1M | – | 1393 |
|
|
2021
Q4 | $1.1M | Buy |
+8,175
| New | +$1.1M | 0.14% | 168 |
|
|
2020
Q4 | – | Sell |
-2,676
| Closed | -$413K | – | 1195 |
|
|
2020
Q3 | $413K | Buy |
+2,676
| New | +$413K | 0.07% | 511 |
|
|
2020
Q1 | – | Sell |
-2,174
| Closed | -$302K | – | 1050 |
|
|
2019
Q4 | $302K | Buy |
+2,174
| New | +$302K | 0.04% | 1018 |
|
|
2016
Q3 | – | Sell |
-13,100
| Closed | -$174K | – | 1756 |
|
|
2016
Q2 | $174K | Sell |
13,100
-5,600
| -30% | -$74.4K | 0.01% | 1609 |
|
|
2016
Q1 | $347K | Buy |
+18,700
| New | +$347K | 0.02% | 1229 |
|